These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 7678939)

  • 1. [ALAT and viral RNA as risk factors in 68 blood donors with anti-hepatitis C antibodies].
    Tullen E; De Saussure P; Soulier-Lauper M
    Schweiz Med Wochenschr; 1993 Jan; 123(3):57-61. PubMed ID: 7678939
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Routes of infection, viremia, and liver disease in blood donors found to have hepatitis C virus infection.
    Conry-Cantilena C; VanRaden M; Gibble J; Melpolder J; Shakil AO; Viladomiu L; Cheung L; DiBisceglie A; Hoofnagle J; Shih JW
    N Engl J Med; 1996 Jun; 334(26):1691-6. PubMed ID: 8637513
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Prevalence of anti-HCV (C100-3) antibodies in 20.373 blood donors].
    Zufferey C; Lavanchy D; Reiff M; Schneider P; Frei P; Pécoud A; Gonvers JJ
    Schweiz Med Wochenschr; 1992 Oct; 122(41):1524-9. PubMed ID: 1411411
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of hepatitis C virus antibodies and genotypes in asymptomatic, first-time blood donors in Namibia.
    Vardas E; Sitas F; Seidel K; Casteling A; Sim J
    Bull World Health Organ; 1999; 77(12):965-72. PubMed ID: 10680243
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enzyme-linked immunosorbent assay for antibodies against the capsid protein of hepatitis C virus with a synthetic oligopeptide.
    Okamoto H; Munekata E; Tsuda F; Takahashi K; Yotsumoto S; Tanaka T; Tachibana K; Akahane Y; Sugai Y; Miyakawa Y
    Jpn J Exp Med; 1990 Aug; 60(4):223-33. PubMed ID: 1963454
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A comparative analysis of blood donors with antibodies to the hepatitis C virus, positivity for the hepatitis B surface antigen and hypertransaminasemia in Asturias].
    Suárez A; Riestra S; Rodríguez M; Linares A; Otero L; Rodrigo L
    Med Clin (Barc); 1994 Jul; 103(6):209-13. PubMed ID: 7967864
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does the healthy hepatitis C virus carrier state really exist? An analysis using polymerase chain reaction.
    Prieto M; Olaso V; Verdú C; Córdoba J; Gisbert C; Rayón M; Carrasco D; Berenguer M; Higón MD; Berenguer J
    Hepatology; 1995 Aug; 22(2):413-7. PubMed ID: 7635408
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Significance of hepatitis C virus antibodies in asymptomatic blood donors].
    Zaugg PY; Joller-Jemelka HI; Skruzny Z; Frey-Wettstein M; Bernardi M; Havelka J; Wicki AN; Bühler H
    Schweiz Med Wochenschr; 1995 Apr; 125(15):758-61. PubMed ID: 7537893
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatitis C virus infection in volunteer blood donors in Taiwan. Evaluation by hepatitis C antibody assays and the polymerase chain reaction.
    Wang JT; Wang TH; Sheu JC; Tsai SJ; Hsieh YS; Lin DT; Wang CY; Chen DS
    Arch Pathol Lab Med; 1993 Feb; 117(2):152-6. PubMed ID: 8381269
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The problem of hepatitis C virus infection in blood donors. Clinico-epidemiological, virological and histological evaluation].
    Sookoian S; Castaño G; Castiglioni T; Pilar S; Viudez P; González J; Frider B
    Medicina (B Aires); 1997; 57(6):699-707. PubMed ID: 9674191
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibodies to hepatitis C virus and hepatitis C virus RNA in Chinese blood donors determined by ELISA, recombinant immunoblot assay and polymerase chain reaction.
    Zhang YY; Guo LS; Hao LJ; Hansson BG; Widell A; Nordenfelt E
    Chin Med J (Engl); 1993 Mar; 106(3):171-4. PubMed ID: 7686839
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence, severity, and risk factors of liver disease in blood donors positive in a second-generation anti-hepatitis C virus screening test.
    Serfaty L; Nousbaum JB; Elghouzzi MH; Giral P; Legendre C; Poupon R
    Hepatology; 1995 Mar; 21(3):725-9. PubMed ID: 7875670
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Examination of a Berlin blood donation branch for antibodies to hepatitis C virus with the anti-HCV test and for circulating HCV-RNA using polymerase chain reaction].
    Zimmermann R; König V; Bauditz J; Zeiler T; Zingsem J; Heuft HG; Hopf U; Huhn D; Eckstein R
    Beitr Infusionsther; 1992; 30():38-41. PubMed ID: 1284740
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibodies to hepatitis C virus: a cross-sectional study in patients attending a trauma unit or admitted to hospital for elective surgery.
    García-Bengoechea M; Emparanza JI; Sarriugarte A; Cortés A; Vega JL; González F; Arenas JI
    Eur J Gastroenterol Hepatol; 1995 Mar; 7(3):237-41. PubMed ID: 7538032
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Hepatitis C virus antibody in the serum of blood donors].
    Barna TK; Ozsvár Z; Szendrényi V; Gál G
    Orv Hetil; 1996 Mar; 137(10):507-11. PubMed ID: 8713664
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Frequency of hepatitis C viral RNA in anti-hepatitis C virus non- reactive blood donors with normal alanine aminotransferase.
    Ali N; Moinuddin ; Ahmed SA; Chotani RA; Fisher-Hoch SP
    J Coll Physicians Surg Pak; 2010 Oct; 20(10):662-6. PubMed ID: 20943108
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidemiological, biological and histological characterization of patients with indeterminate third-generation recombinant immunoblot assay antibody results for hepatitis C virus.
    Ríos M; Diago M; Rivera P; Tuset C; Cors R; García V; Carbonel P; Gonzalez C
    J Viral Hepat; 2006 Mar; 13(3):177-81. PubMed ID: 16475993
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of hepatitis C virus antibodies in blood donors in Malaysia.
    Duraisamy G; Zuridah H; Ariffin MY
    Med J Malaysia; 1993 Sep; 48(3):313-6. PubMed ID: 7514258
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of serum hepatitis C virus RNA in HCV antibody-seropositive volunteer blood donors.
    McGuinness PH; Bishop GA; Lien A; Wiley B; Parsons C; McCaughan GW
    Hepatology; 1993 Sep; 18(3):485-90. PubMed ID: 7689526
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human immunodeficiency virus infection as risk factor for mother-to-child hepatitis C virus transmission; persistence of anti-hepatitis C virus in children is associated with the mother's anti-hepatitis C virus immunoblotting pattern.
    Manzini P; Saracco G; Cerchier A; Riva C; Musso A; Ricotti E; Palomba E; Scolfaro C; Verme G; Bonino F
    Hepatology; 1995 Feb; 21(2):328-32. PubMed ID: 7843701
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.